---

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of
The Securities Exchange Act of 1934

For the month of January, 2005

Commission File Number: 000-31092

MEDICURE INC.
(Translation of registrant’s name into English)

4-1200 Waverley Street
Winnipeg, MB Canada R3T 0P4
(Address of principal executive offices)

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F)

(Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.)

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _______

---

SUBMITTED HEREWITH

Exhibits

	99.1	Second Quarter Report for the Period Ended November 30, 2004
	99.2	Form 52-109FT2 – Certification of CEO
	99.3	Form 52-109FT2 – Certification of CFO
	99.4	Confirmation of Mailing of First Quarter Financial Statements
	99.5	Press Release dated January 13, 2005

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MEDICURE INC.
Date: January 17, 2005	By:	/s/ Dr. Albert D. Friesen
		Dr. Albert D. Friesen
		President & CEO

---